SCHEMBL1798282

SCHEMBL1798282

COC(=O)c1cc(Cl)ccc1NC(=O)CN(C)CC(=O)NC(c1ccccc1)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.60
L3MBTL1 Q9Y468 2/20 0.60
KDM4E B2RXH2 2/20 0.52
NPSR1 Q6W5P4 2/20 0.52
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
LMNA P02545 1/20 0.47
MAPT P10636 4/20 0.46
GAA P10253 3/20 0.46
RECQL P46063 1/20 0.45
NPC1 O15118 1/20 0.44
ATM Q13315 1/20 0.44
POLB P06746 1/20 0.43
PKM P14618 1/20 0.43
NCOA1 Q15788 1/20 0.43
NCOA3 Q9Y6Q9 1/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1799375 0.90 ALDH1A1 (0.58) ALDH1A1L3MBTL1KDM4ENPSR1MEN1
Hydrochloric Acid SCHEMBL1800403 0.89 ALDH1A1 (0.57) ALDH1A1L3MBTL1KDM4ENPSR1MEN1
SCHEMBL1798978 0.85 SERPINE1 (0.53) ALDH1A1L3MBTL1KDM4EMEN1KMT2A
SCHEMBL1796237 0.84 ALDH1A1 (0.54) ALDH1A1L3MBTL1KDM4ENPSR1MEN1
SCHEMBL1796902 0.81 TP53 (0.65) ALDH1A1L3MBTL1KDM4ENPSR1MEN1
SCHEMBL1800967 0.81 CRHBP (0.46) ALDH1A1L3MBTL1KDM4ENPSR1MEN1
SCHEMBL1796719 0.80 SERPINE1 (0.63) ALDH1A1L3MBTL1KDM4ENPSR1
SCHEMBL420909 0.80 NPSR1 (0.56) ALDH1A1KDM4ENPSR1MEN1KMT2A
SCHEMBL418724 0.77 ALDH1A1 (0.52) ALDH1A1L3MBTL1KDM4ENPSR1MEN1
SCHEMBL1796300 0.75 ALDH1A1 (0.48) ALDH1A1KDM4EMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 US disclosed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 ALDH1A1 800/4885L3MBTL1 2672/4885KDM4E 4309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.